ANI PHARMACEUTICALS, INC Operating Lease, Liability, Current
ANI PHARMACEUTICALS, INC (ANIP) had Operating Lease, Liability, Current of $1.92 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-02-27
- 2025-12-31: Operating Lease, Liability, Current $1.92M.
- 2024-12-31: Operating Lease, Liability, Current $1.80M.
- 2023-12-31: Operating Lease, Liability, Current $1.56M.
- 2022-12-31: Operating Lease, Liability, Current $684.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2025-12-31 | $1.92M 10-K · filed 2026-02-27 |
| 2024-12-31 | $1.80M 10-K · filed 2025-02-28 |
| 2023-12-31 | $1.56M 10-K · filed 2024-02-29 |
| 2022-12-31 | $684.00K 10-K · filed 2023-03-09 |
| 2022-09-30 | $604.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $413.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $380.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $387.00K 10-K · filed 2022-03-15 |
| 2021-09-30 | $130.00K 10-Q · filed 2021-11-01 |
| 2021-06-30 | $128.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $132.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $129.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $181.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $201.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $199.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $197.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $177.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $175.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $165.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |